NR4A1 and cancer: Patient variables include age, race and body mass index; cancer variables include stage, grade and proliferative status, hormone receptor and human epidermal growth factor receptor (Her)2 status; and treatment variables include adjuvant chemo-, hormone- and biotherapy.